Novo Integrated Sciences Inc
NVOS
Get informed when a big investor buys or sells
+ FollowMarket Cap$394.61K
Close$
Share Statistics
| Market cap | $394,605.00 |
|---|---|
| Enterprise Value | $4.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.9 |
| Beta | 4.3 |
| Outstanding Shares | 19,054,523 |
Return
| Return on Equity | -108.56% |
|---|---|
| Return on Assets | -50.30% |
| Return on Invested Capital | -9.39% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | -2.58 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.11 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
December 16, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Novo Integrated Sciences Inc
92 employeesNovo Integrated Sciences, Inc. is a U.S. based provider of multidisciplinary primary care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science. The company believes...